Clinical trial
RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma
NCT03908138 is registered in ClinicalTrials.gov with Shandong Provincial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma
- Lead sponsor
- Shandong Provincial Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- March 30, 2019
- Completion date
- December 31, 2022
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
efficacy, hematologic neoplasms, multiple myeloma, safety